Literature DB >> 15321907

Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.

Timothy J Tucker1, Gatsha Mazithulela.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15321907      PMCID： PMC514216          DOI： 10.1136/bmj.329.7463.454

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

Authors:  Gustavo H Dayan; Lisa Cairns; Nalinee Sangrujee; Anne Mtonga; Van Nguyen; Peter Strebel
Journal:  Vaccine       Date:  2004-01-02       Impact factor: 3.641

2.  Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Mark B Feinberg; Robert C Gallo; Beatrice Hahn; James A Hoxie; Eric Hunter; Bette Korber; Alan Landay; Michael M Lederman; Judy Lieberman; Joseph M McCune; John P Moore; Neal Nathanson; Louis Picker; Douglas Richman; Charles Rinaldo; Mario Stevenson; David I Watkins; Steven M Wolinsky; Jerome A Zack
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

3.  Medicine. The need for a global HIV vaccine enterprise.

Authors:  Richard D Klausner; Anthony S Fauci; Lawrence Corey; Gary J Nabel; Helene Gayle; Seth Berkley; Barton F Haynes; David Baltimore; Chris Collins; R Gordon Douglas; Jose Esparza; Donald P Francis; N K Ganguly; Julie Louise Gerberding; Margaret I Johnston; Michel D Kazatchkine; Andrew J McMichael; Malegapuru W Makgoba; Giuseppe Pantaleo; Peter Piot; Yiming Shao; Edmund Tramont; Harold Varmus; Judith N Wasserheit
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

Review 4.  The clades of HIV: their origins and clinical significance.

Authors:  Justin Stebbing; Graeme Moyle
Journal:  AIDS Rev       Date:  2003 Oct-Dec       Impact factor: 2.500

5.  Policy rebuttal. HIV vaccine trial justified.

Authors:  John G McNeil; Margaret I Johnston; Deborah L Birx; Edmund C Tramont
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

6.  Panel discussion on vaccine development to meet U.S. and international needs. Strategies for reducing the disincentives to HIV vaccine development: description of a successful public-private sector international collaboration.

Authors:  L Bronnenkant
Journal:  AIDS Res Hum Retroviruses       Date:  1994       Impact factor: 2.205
  6 in total
  3 in total

1.  Private sector needs incentives for AIDS vaccine.

Authors:  Benedict Irvine
Journal:  BMJ       Date:  2004-10-23

Review 2.  Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.

Authors:  Flavia Ferrantelli; Stefano Buttò; Aurelio Cafaro; Britta Wahren; Barbara Ensoli
Journal:  Springer Semin Immunopathol       Date:  2006-09-16

Review 3.  Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Authors:  Joalida Smit; Keren Middelkoop; Landon Myer; Graham Lindegger; Leslie Swartz; Soraya Seedat; Tim Tucker; Robin Wood; Linda-Gail Bekker; Dan J Stein
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.